Multi-constituent synergism is responsible for anti-inflammatory effect of Azadirachta indica leaf extract
Abstract Context: Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures. Objective: To fractionate A. indica leaf extracts using bioactivity guided manner for identification of the active anti-inflammatory principles. Materia...
Saved in:
Published in | Pharmaceutical biology Vol. 52; no. 11; pp. 1411 - 1422 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Informa Healthcare USA, Inc
01.11.2014
Taylor & Francis |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Context: Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures.
Objective: To fractionate A. indica leaf extracts using bioactivity guided manner for identification of the active anti-inflammatory principles.
Materials and methods: Polarity-gradient sequential extracts (petroleum ether, chloroform, methanol, and water) of A. indica leaves were screened for their anti-inflammatory potential using the carrageenan-induced rat paw edema model (1 g/kg). The chloroform extract was sequentially fractionated to obtain n-hexane (F-1), n-hexane-chloroform (F-2), and chloroform (F-3) fractions and their inhibitory effect on rat paw edema was evaluated (500 mg/kg). Inhibitory effect of F-2 on granuloma formation, plasma interleukin (IL-1), and tumor necrosis factor (TNF-α) was assessed at the doses of 100, 200, and 400 mg/kg using the cotton pellet assay in rats. Three sub-fractions (SF-1, SF-2, and SF-3) were obtained upon chromatography of F-2, and their inhibitory effect on cyclooxygenase was assessed at 200 µg/mL concentration. The sub-fractions were subjected to gas chromatography-mass spectrometry (GC-MS).
Results: All the extracts showed significant anti-inflammatory effect; however, chloroform extract was the most effective against paw edema (53.25% inhibition). The three fractions of chloroform extract showed significant effect, while F-2 being the most potent (51.02%). F-2 demonstrated dose-dependent inhibition of granuloma and cytokines. Interestingly, all the sub-fractions of F-2 inhibited COX-1 and COX-2 with almost equal potential. GC-MS revealed that chemically the sub-fractions were totally different from each other.
Discussion and conclusion: Anti-inflammatory effect of A. indica is a result of cumulative and synergistic effects of diversified constituents with varying polarities that collectively exert the effect via suppression of cyclo-oxygenases and cytokines (IL-1 and TNF-α). |
---|---|
AbstractList | Context: Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures.
Objective: To fractionate A. indica leaf extracts using bioactivity guided manner for identification of the active anti-inflammatory principles.
Materials and methods: Polarity-gradient sequential extracts (petroleum ether, chloroform, methanol, and water) of A. indica leaves were screened for their anti-inflammatory potential using the carrageenan-induced rat paw edema model (1 g/kg). The chloroform extract was sequentially fractionated to obtain n-hexane (F-1), n-hexane-chloroform (F-2), and chloroform (F-3) fractions and their inhibitory effect on rat paw edema was evaluated (500 mg/kg). Inhibitory effect of F-2 on granuloma formation, plasma interleukin (IL-1), and tumor necrosis factor (TNF-α) was assessed at the doses of 100, 200, and 400 mg/kg using the cotton pellet assay in rats. Three sub-fractions (SF-1, SF-2, and SF-3) were obtained upon chromatography of F-2, and their inhibitory effect on cyclooxygenase was assessed at 200 µg/mL concentration. The sub-fractions were subjected to gas chromatography-mass spectrometry (GC-MS).
Results: All the extracts showed significant anti-inflammatory effect; however, chloroform extract was the most effective against paw edema (53.25% inhibition). The three fractions of chloroform extract showed significant effect, while F-2 being the most potent (51.02%). F-2 demonstrated dose-dependent inhibition of granuloma and cytokines. Interestingly, all the sub-fractions of F-2 inhibited COX-1 and COX-2 with almost equal potential. GC-MS revealed that chemically the sub-fractions were totally different from each other.
Discussion and conclusion: Anti-inflammatory effect of A. indica is a result of cumulative and synergistic effects of diversified constituents with varying polarities that collectively exert the effect via suppression of cyclo-oxygenases and cytokines (IL-1 and TNF-α). Abstract Context: Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures. Objective: To fractionate A. indica leaf extracts using bioactivity guided manner for identification of the active anti-inflammatory principles. Materials and methods: Polarity-gradient sequential extracts (petroleum ether, chloroform, methanol, and water) of A. indica leaves were screened for their anti-inflammatory potential using the carrageenan-induced rat paw edema model (1 g/kg). The chloroform extract was sequentially fractionated to obtain n-hexane (F-1), n-hexane-chloroform (F-2), and chloroform (F-3) fractions and their inhibitory effect on rat paw edema was evaluated (500 mg/kg). Inhibitory effect of F-2 on granuloma formation, plasma interleukin (IL-1), and tumor necrosis factor (TNF-α) was assessed at the doses of 100, 200, and 400 mg/kg using the cotton pellet assay in rats. Three sub-fractions (SF-1, SF-2, and SF-3) were obtained upon chromatography of F-2, and their inhibitory effect on cyclooxygenase was assessed at 200 µg/mL concentration. The sub-fractions were subjected to gas chromatography-mass spectrometry (GC-MS). Results: All the extracts showed significant anti-inflammatory effect; however, chloroform extract was the most effective against paw edema (53.25% inhibition). The three fractions of chloroform extract showed significant effect, while F-2 being the most potent (51.02%). F-2 demonstrated dose-dependent inhibition of granuloma and cytokines. Interestingly, all the sub-fractions of F-2 inhibited COX-1 and COX-2 with almost equal potential. GC-MS revealed that chemically the sub-fractions were totally different from each other. Discussion and conclusion: Anti-inflammatory effect of A. indica is a result of cumulative and synergistic effects of diversified constituents with varying polarities that collectively exert the effect via suppression of cyclo-oxygenases and cytokines (IL-1 and TNF-α). CONTEXTAzadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures.OBJECTIVETo fractionate A. indica leaf extracts using bioactivity guided manner for identification of the active anti-inflammatory principles.MATERIALS AND METHODSPolarity-gradient sequential extracts (petroleum ether, chloroform, methanol, and water) of A. indica leaves were screened for their anti-inflammatory potential using the carrageenan-induced rat paw edema model (1 g/kg). The chloroform extract was sequentially fractionated to obtain n-hexane (F-1), n-hexane-chloroform (F-2), and chloroform (F-3) fractions and their inhibitory effect on rat paw edema was evaluated (500 mg/kg). Inhibitory effect of F-2 on granuloma formation, plasma interleukin (IL-1), and tumor necrosis factor (TNF-α) was assessed at the doses of 100, 200, and 400 mg/kg using the cotton pellet assay in rats. Three sub-fractions (SF-1, SF-2, and SF-3) were obtained upon chromatography of F-2, and their inhibitory effect on cyclooxygenase was assessed at 200 µg/mL concentration. The sub-fractions were subjected to gas chromatography-mass spectrometry (GC-MS).RESULTSAll the extracts showed significant anti-inflammatory effect; however, chloroform extract was the most effective against paw edema (53.25% inhibition). The three fractions of chloroform extract showed significant effect, while F-2 being the most potent (51.02%). F-2 demonstrated dose-dependent inhibition of granuloma and cytokines. Interestingly, all the sub-fractions of F-2 inhibited COX-1 and COX-2 with almost equal potential. GC-MS revealed that chemically the sub-fractions were totally different from each other.DISCUSSION AND CONCLUSIONAnti-inflammatory effect of A. indica is a result of cumulative and synergistic effects of diversified constituents with varying polarities that collectively exert the effect via suppression of cyclo-oxygenases and cytokines (IL-1 and TNF-α). Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures. To fractionate A. indica leaf extracts using bioactivity guided manner for identification of the active anti-inflammatory principles. Polarity-gradient sequential extracts (petroleum ether, chloroform, methanol, and water) of A. indica leaves were screened for their anti-inflammatory potential using the carrageenan-induced rat paw edema model (1 g/kg). The chloroform extract was sequentially fractionated to obtain n-hexane (F-1), n-hexane-chloroform (F-2), and chloroform (F-3) fractions and their inhibitory effect on rat paw edema was evaluated (500 mg/kg). Inhibitory effect of F-2 on granuloma formation, plasma interleukin (IL-1), and tumor necrosis factor (TNF-α) was assessed at the doses of 100, 200, and 400 mg/kg using the cotton pellet assay in rats. Three sub-fractions (SF-1, SF-2, and SF-3) were obtained upon chromatography of F-2, and their inhibitory effect on cyclooxygenase was assessed at 200 µg/mL concentration. The sub-fractions were subjected to gas chromatography-mass spectrometry (GC-MS). All the extracts showed significant anti-inflammatory effect; however, chloroform extract was the most effective against paw edema (53.25% inhibition). The three fractions of chloroform extract showed significant effect, while F-2 being the most potent (51.02%). F-2 demonstrated dose-dependent inhibition of granuloma and cytokines. Interestingly, all the sub-fractions of F-2 inhibited COX-1 and COX-2 with almost equal potential. GC-MS revealed that chemically the sub-fractions were totally different from each other. Anti-inflammatory effect of A. indica is a result of cumulative and synergistic effects of diversified constituents with varying polarities that collectively exert the effect via suppression of cyclo-oxygenases and cytokines (IL-1 and TNF-α). |
Author | Asmawi, Mohd Zaini Sadikun, Amirin Khadeer Ahamed, Mohamed B. Umar, Muhammad Ihtisham Ahmad, Ashfaq Altaf, Rabia Atangwho, Item Justin Abdul Majid, A. M. S. |
Author_xml | – sequence: 1 givenname: Muhammad Ihtisham surname: Umar fullname: Umar, Muhammad Ihtisham email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com organization: School of Pharmaceutical Sciences, Universiti Sains Malaysia – sequence: 2 givenname: Mohd Zaini surname: Asmawi fullname: Asmawi, Mohd Zaini email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com organization: School of Pharmaceutical Sciences, Universiti Sains Malaysia – sequence: 3 givenname: Amirin surname: Sadikun fullname: Sadikun, Amirin email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com organization: School of Pharmaceutical Sciences, Universiti Sains Malaysia – sequence: 4 givenname: A. M. S. surname: Abdul Majid fullname: Abdul Majid, A. M. S. email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com organization: EMAN Testing and Research Laboratories, School of Pharmaceutical Sciences, Universiti Sains Malaysia – sequence: 5 givenname: Item Justin surname: Atangwho fullname: Atangwho, Item Justin email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com organization: School of Pharmaceutical Sciences, Universiti Sains Malaysia – sequence: 6 givenname: Mohamed B. surname: Khadeer Ahamed fullname: Khadeer Ahamed, Mohamed B. email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com organization: EMAN Testing and Research Laboratories, School of Pharmaceutical Sciences, Universiti Sains Malaysia – sequence: 7 givenname: Rabia surname: Altaf fullname: Altaf, Rabia email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com organization: School of Pharmaceutical Sciences, Universiti Sains Malaysia – sequence: 8 givenname: Ashfaq surname: Ahmad fullname: Ahmad, Ashfaq email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com organization: School of Pharmaceutical Sciences, Universiti Sains Malaysia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25026347$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kE1v1DAQhiNURD_gHyDkI5csthMnzgVUVRSQirjA2ZrYY9Yrx15sR7D8-nq1LRKXnjzyPPPO6LlszkIM2DSvGd10jE7vWCcl5XTacMr6jZwEZeOz5oKNfd8KxoazWlekPTLnzWXOO0qp6DrxojnngvKh68eLZvd19cW1OoZcXFkxFJIPAdNPlxfiMkmY97XnZo_ExkQgVNoF62FZoMR0IGgt6kKiJdd_wbgEeluAuGCcBuIRLME_pf6Wl81zCz7jq4f3qvlx-_H7zef27tunLzfXd63umSytZB0MSFEMXM7cwCAlaDMhZ1aLWRozS2oM5xMXYMZpstRKIXU_AgzUGuiumren3H2Kv1bMRS0ua_QeAsY1KzYwzqWYBlbR_oTqFHNOaNU-uQXSQTGqjpbVo2V1tKxOluvYm4cN67yg-Tf0qLUCH05ANRXTAr9j8kYVOPiYbIKgXT7GP7ni_X8JWwRfthoSql1cU6gCn77xHogKo3Q |
CitedBy_id | crossref_primary_10_3389_fphar_2022_890938 crossref_primary_10_2174_1871520620666201005100132 crossref_primary_10_2174_1389201022666210702120956 crossref_primary_10_1007_s13205_021_02745_4 crossref_primary_10_1016_j_jep_2021_114179 crossref_primary_10_1016_j_jtcme_2021_09_003 crossref_primary_10_15446_rfnam_v73n3_80501 crossref_primary_10_2147_CCID_S342227 crossref_primary_10_3390_molecules26113456 crossref_primary_10_3390_molecules27072323 crossref_primary_10_1016_j_envpol_2021_118660 crossref_primary_10_29252_mlj_13_1_21 crossref_primary_10_1038_srep45479 crossref_primary_10_1016_S1875_5364_17_30076_6 crossref_primary_10_3390_molecules21101321 crossref_primary_10_3390_molecules27113536 |
Cites_doi | 10.1016/S0031-9422(00)00456-8 10.1016/S1995-7645(11)60247-2 10.1590/S0102-695X2012005000041 10.3390/molecules17078720 10.2174/0929867033368583 10.1055/s-0029-1185315 10.1016/S0162-3109(99)00132-0 10.1074/jbc.M112.341321 10.1046/j.1365-2672.1998.00324.x 10.1074/jbc.M110.169334 10.1007/s12263-010-0194-6 10.1371/journal.pone.0016999 10.1208/s12248-011-9279-4 10.1016/0022-1759(95)00127-V 10.4103/0974-8490.91028 10.1016/j.jep.2009.07.004 10.1002/ptr.1474 10.1016/j.semcancer.2012.02.008 10.1007/s10787-008-8032-9 10.1055/s-2007-971670 10.1016/j.jep.2003.12.004 10.2174/1568011053174828 |
ContentType | Journal Article |
Copyright | 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted 2014 |
Copyright_xml | – notice: 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted 2014 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.3109/13880209.2014.895017 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1744-5116 |
EndPage | 1422 |
ExternalDocumentID | 10_3109_13880209_2014_895017 25026347 895017 |
Genre | Original Articles Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 00X 0R~ 0YH 123 29O 4.4 53G 5VS 7X7 8FI 8FJ AALIY ABDBF ABPTK ABUWG ACGEJ ACGFS ADBBV ADCVX ADRBQ ADXPE AENEX AEYQI AFKRA AFKVX AJWEG ALIIL ALMA_UNASSIGNED_HOLDINGS AOIJS ARJSQ AWYRJ BABNJ BCNDV BENPR BPHCQ BVXVI CAG COF CS3 CZDIS DRXRE DU5 DWTOO EAL EAP EBD EBS EJD EMK EMOBN EPL EPT EST ESX F5P FYUFA GROUPED_DOAJ H13 HYE HZ~ J.N KTTOD M44 M4Z ML~ O9- P2P PIMPY PQEST PQQKQ PQUKI PROAC Q~Q RPM SV3 TFDNU TFL TFW TUS UKHRP V1S ~1N AAHBH ALIPV CCPQU CGR CUY CVF ECM EIF HMCUK NPM NUSFT TDBHL AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c418t-813a6e0e5628b2da688acd9e21fc5b8ddb80dd22925ad799f0f858c47aa60fda3 |
IEDL.DBID | 0YH |
ISSN | 1388-0209 |
IngestDate | Sat Aug 17 00:01:22 EDT 2024 Fri Aug 23 01:33:53 EDT 2024 Sat Sep 28 08:07:43 EDT 2024 Tue Jun 13 19:57:31 EDT 2023 Wed Jun 21 08:18:34 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | carrageenan assay TNF-α interlukin-1 Bioactivity guided fractionation cotton pellet assay cyclooxygenase cytokines |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c418t-813a6e0e5628b2da688acd9e21fc5b8ddb80dd22925ad799f0f858c47aa60fda3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 25026347 |
PQID | 1612285961 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_1612285961 crossref_primary_10_3109_13880209_2014_895017 informaworld_taylorfrancis_310_3109_13880209_2014_895017 pubmed_primary_25026347 informahealthcare_journals_10_3109_13880209_2014_895017 |
PublicationCentury | 2000 |
PublicationDate | 20141100 11/1/2014 2014-Nov 2014-11-00 20141101 |
PublicationDateYYYYMMDD | 2014-11-01 |
PublicationDate_xml | – month: 11 year: 2014 text: 20141100 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Pharmaceutical biology |
PublicationTitleAlternate | Pharm Biol |
PublicationYear | 2014 |
Publisher | Informa Healthcare USA, Inc Taylor & Francis |
Publisher_xml | – name: Informa Healthcare USA, Inc – name: Taylor & Francis |
References | Ahamed MBK (CIT0001) 2009; 75 Mahapatra S (CIT0014) 2011; 13 Koul A (CIT0013) 2009; 17 Namsa ND (CIT0017) 2009; 125 Petrovsky N (CIT0020) 1995; 186 Schumacher M (CIT0025) 2011; 6 Goodman LS (CIT0008) 2001 Phillipson JD (CIT0021) 2001; 56 Jones PJ (CIT0009) 2002; 166 Subapriya R (CIT0027) 2005; 5 Dasgupta T (CIT0005) 2004; 92 Mathur M (CIT0016) 2012; 22 Samud AM (CIT0024) 1999; 43 Ezhilan B (CIT0006) 2012; 4 Manogaran S (CIT0015) 1998; 18 Owoyele BV (CIT0019) 2008; 2 Kaur G (CIT0011) 2004; 18 Kanterman J (CIT0010) 2012; 22 Rasoanaivo P (CIT0023) 2011; 10 Anosike CA (CIT0003) 2012; 5 Takigawa TK (CIT0028) 2011; 6 Thoh M (CIT0030) 2011; 286 Ramos-Nino ME (CIT0022) 1998; 84 Umar MI (CIT0031) 2012; 17 Okpanyi SN (CIT0018) 1981; 41 CIT0007 Alam A (CIT0002) 2012; 287 Biswas K (CIT0004) 2002; 82 |
References_xml | – volume: 56 start-page: 237 year: 2001 ident: CIT0021 publication-title: Phytochemistry doi: 10.1016/S0031-9422(00)00456-8 contributor: fullname: Phillipson JD – volume: 5 start-page: 62 year: 2012 ident: CIT0003 publication-title: Asian Pac J Trop Med doi: 10.1016/S1995-7645(11)60247-2 contributor: fullname: Anosike CA – volume: 22 start-page: 994 year: 2012 ident: CIT0016 publication-title: Braz J Pharmacog doi: 10.1590/S0102-695X2012005000041 contributor: fullname: Mathur M – volume: 17 start-page: 8720 year: 2012 ident: CIT0031 publication-title: Molecules doi: 10.3390/molecules17078720 contributor: fullname: Umar MI – volume: 2 start-page: 219 year: 2008 ident: CIT0019 publication-title: J Med Plant Res contributor: fullname: Owoyele BV – ident: CIT0007 doi: 10.2174/0929867033368583 – volume: 75 start-page: 478 year: 2009 ident: CIT0001 publication-title: Planta Med doi: 10.1055/s-0029-1185315 contributor: fullname: Ahamed MBK – volume: 43 start-page: 311 year: 1999 ident: CIT0024 publication-title: Immunopharmacology doi: 10.1016/S0162-3109(99)00132-0 contributor: fullname: Samud AM – volume: 287 start-page: 24844 year: 2012 ident: CIT0002 publication-title: J Biol Chem doi: 10.1074/jbc.M112.341321 contributor: fullname: Alam A – volume: 84 start-page: 207 year: 1998 ident: CIT0022 publication-title: J Appl Microbiol doi: 10.1046/j.1365-2672.1998.00324.x contributor: fullname: Ramos-Nino ME – volume: 286 start-page: 4690 year: 2011 ident: CIT0030 publication-title: J Biol Chem doi: 10.1074/jbc.M110.169334 contributor: fullname: Thoh M – volume: 166 start-page: 1555 year: 2002 ident: CIT0009 publication-title: Can Med Assoc J contributor: fullname: Jones PJ – volume: 6 start-page: 149 year: 2011 ident: CIT0025 publication-title: Genes Nutr doi: 10.1007/s12263-010-0194-6 contributor: fullname: Schumacher M – volume: 6 start-page: 1 year: 2011 ident: CIT0028 publication-title: PLoS One doi: 10.1371/journal.pone.0016999 contributor: fullname: Takigawa TK – volume: 13 start-page: 365 year: 2011 ident: CIT0014 publication-title: AAPS J doi: 10.1208/s12248-011-9279-4 contributor: fullname: Mahapatra S – volume: 186 start-page: 37 year: 1995 ident: CIT0020 publication-title: J Immunol Methods doi: 10.1016/0022-1759(95)00127-V contributor: fullname: Petrovsky N – volume: 82 start-page: 1336 year: 2002 ident: CIT0004 publication-title: Curr Sci contributor: fullname: Biswas K – volume: 4 start-page: 11 year: 2012 ident: CIT0006 publication-title: Pharmacog Res doi: 10.4103/0974-8490.91028 contributor: fullname: Ezhilan B – volume: 10 start-page: 1 issue: 4 year: 2011 ident: CIT0023 publication-title: Malaria J contributor: fullname: Rasoanaivo P – volume-title: Goodman & Gilman's The Pharmacological Basis of Therapeutics year: 2001 ident: CIT0008 contributor: fullname: Goodman LS – volume: 125 start-page: 234 year: 2009 ident: CIT0017 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2009.07.004 contributor: fullname: Namsa ND – volume: 18 start-page: 419 year: 2004 ident: CIT0011 publication-title: Phytother Res doi: 10.1002/ptr.1474 contributor: fullname: Kaur G – volume: 22 start-page: 307 year: 2012 ident: CIT0010 publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2012.02.008 contributor: fullname: Kanterman J – volume: 17 start-page: 29 year: 2009 ident: CIT0013 publication-title: Inflammopharmacology doi: 10.1007/s10787-008-8032-9 contributor: fullname: Koul A – volume: 41 start-page: 34 year: 1981 ident: CIT0018 publication-title: Planta Med doi: 10.1055/s-2007-971670 contributor: fullname: Okpanyi SN – volume: 92 start-page: 23 year: 2004 ident: CIT0005 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2003.12.004 contributor: fullname: Dasgupta T – volume: 18 start-page: 29 year: 1998 ident: CIT0015 publication-title: Ancient Sci Life contributor: fullname: Manogaran S – volume: 5 start-page: 149 year: 2005 ident: CIT0027 publication-title: Curr Med Chem Anti-Cancer Agents doi: 10.2174/1568011053174828 contributor: fullname: Subapriya R |
SSID | ssj0005335 |
Score | 2.1797829 |
Snippet | Abstract
Context: Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures.
Objective:... Context: Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures. Objective: To... Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures. To fractionate A. indica leaf... CONTEXTAzadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures.OBJECTIVETo fractionate... |
SourceID | proquest crossref pubmed informaworld informahealthcare |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1411 |
SubjectTerms | Animals Anti-Inflammatory Agents - isolation & purification Anti-Inflammatory Agents - therapeutic use Azadirachta Bioactivity guided fractionation carrageenan assay cotton pellet assay cyclooxygenase cytokines Dose-Response Relationship, Drug Drug Synergism Edema - blood Edema - drug therapy Edema - pathology Female Humans interlukin-1 Male Plant Extracts - isolation & purification Plant Extracts - therapeutic use Plant Leaves Rats Rats, Sprague-Dawley Sheep TNF-α Treatment Outcome |
Title | Multi-constituent synergism is responsible for anti-inflammatory effect of Azadirachta indica leaf extract |
URI | https://www.tandfonline.com/doi/abs/10.3109/13880209.2014.895017 https://www.ncbi.nlm.nih.gov/pubmed/25026347 https://search.proquest.com/docview/1612285961 |
Volume | 52 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwELWAXrggaAssH5WRECcMiZM4zhGholWlIg4gwSkaf4lFsItIOCy_npl4l6VUgMQlkg8TO3njzDie98zYri8xyJRZKirjS5ErZ0UFGV6cMxmkyoEn7vDfU9W_yP9cFpevWPxUVklr6BCFIrpvNU1uMN0JJKRjeZiSgIlMiGaS5ge6KrC3efZNYuZNnp5c9WdFHll3xCZZCDKJ5Ll37_JPcFqeSJdevxRivZEzfT8p7YLTyTJbmmSV_Ci6wQqb88PvbO8sylKP9_n5jGXV7PM9fjYTrB7_YDcdC1fYUSwcwDDEmzFxAgfNHR80_GFaR3vrOY6LIxgDgUNEZ7rrNul5rArho8CPngCjJNjrFjhth1vgtx4CxxhAfKyf7OLk9_lxX0zOYBA2T3UrdJqB8onHNEkb6UBpDdZVXqbBFkYjojpxTspKFuDKqgpJ0IW2eQmgkuAgW2ULw9HQrzMOoUisMhCSwuTaOANoh01dWtAyqB4T05df30epjRqXKARWPQWrJrDqCFaPlf8hVE9mYPOJpX6NY912P0dCPMmEzD4y3ZliXuNEpN0VGPrRI3aIuSKpAaq0x9aiM7w8BuaZUmV5ufH1jjfZIrUiDXKLLbQPj34b86HW_Opc_hlHOgNL |
link.rule.ids | 315,786,790,27533,27955,27956,59496,59497,61571,61572 |
linkProvider | Taylor & Francis |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagHOCCynvLy0iop5o6L8c-VohqgbbqYSvByZr4oS5qd1GTHra_npk46fJQQeISKYomTvKNM2N7vs-MvQ01Bpm6yIRpQi1K5Z0wUODB-6aATHkIxB0-PFLTk_LTl2qsJmyHskoaQ8ckFNH_q6lz02T0bj_ElGY3IwWTXBLPJCvfaVNhc7fZncqUhsZf8ut0XeVR9HtskoUgk8Seu_Euv0SnzUG79PS6Eus3PdObs9I-Ou1vsvtDWsn3kh88YLfC4iHbPk661KsdPlvTrNodvs2P14rVq0fsW0_DFW6ZKgcwDvF2RaTAeXvO5y2_GAtpzwLH5-KIxlzgI6I3nfer9DyVhfBl5HtXgGES3GkHnNbDHfCzAJFjECBC1mN2sv9h9n4qhk0YhCsz3QmdFaCCDJgn6Sb3oLQG503Is-iqRiOkWnqf5yavwNfGRBl1pV1ZAygZPRRP2MZiuQjPGIdYSacaiLJqSt34BtAOT3XtQOdRTZgYP779nrQ2LI5RCCw7gmUJLJvAmrD6D4Ts0AXbf1jqn3G0XT87EtNWJmT2N9M3I-YWeyItr8AiLC-xQUwWSQ5QZRP2NDnD9Wtgopmroqy3_r_h1-zudHZ4YA8-Hn1-zu7RlcSJfME2uovL8BKTo6551bv_D2TWBsE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELZaKlW9IPpeoK0rVZxwcV6OfURtV9sX2gNI9GRN_BBbwS4i4bD8embiXZa2opV6iRRFEzv5xplxPN9nxt6FGoNMXWTCNKEWpfJOGCjw4H1TQKY8BOIOfz9Qo6Pyy3F1fIvFT2WVNIeOSSii_1bT4D73ca-fYUqzl5GASS6JZpKV77WpsLX77EFlSkM-Ln-MVkUeRb_FJlkIMknkuTvv8ktw2lhIl57cFGL9Jmd6d1LaB6fhBltfZJV8P7nBY3YvTJ-wnXGSpZ7v8sMVy6rd5Tt8vBKsnj9lP3sWrnCzVDiAYYi3c-IETtozPmn5xbKO9jRw7BdHMCYCu4jOdNYv0vNUFcJnke9fAUZJcCcdcFoOd8BPA0SOMYD4WM_Y0fDT4YeRWOzBIFyZ6U7orAAVZMA0STe5B6U1OG9CnkVXNRoR1dL7PDd5Bb42JsqoK-3KGkDJ6KF4ztams2l4yTjESjrVQJRVU-rGN4B2eKprBzqPasDE8uXb8yS1YXGKQmDZJViWwLIJrAGr_0DILkZg-w9LfRtH2_U_R2LayYTM_mb6dom5xYFIqyswDbNLbBBzRVIDVNmAvUjOcPMYmGfmqijrzf9v-A17OP44tN8-H3zdYo_oQmJEbrO17uIyvMLUqGte995_Dbi6Beo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multi-constituent+synergism+is+responsible+for+anti-inflammatory+effect+of+Azadirachta+indica+leaf+extract&rft.jtitle=Pharmaceutical+biology&rft.au=Umar%2C+Muhammad+Ihtisham&rft.au=Asmawi%2C+Mohd+Zaini&rft.au=Sadikun%2C+Amirin&rft.au=Abdul+Majid%2C+A.+M.+S.&rft.date=2014-11-01&rft.pub=Taylor+%26+Francis&rft.issn=1388-0209&rft.eissn=1744-5116&rft.volume=52&rft.issue=11&rft.spage=1411&rft.epage=1422&rft_id=info:doi/10.3109%2F13880209.2014.895017&rft.externalDocID=895017 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1388-0209&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1388-0209&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1388-0209&client=summon |